Article Versions Notes

Simón Serrano S, Grönberg A, Longato L, Rombouts K, Kuo J, Gregory M, Moss S, Elmér E, Mazza G, Gallay P, et al. Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis. Cells. 2019; 8(11):1409. https://doi.org/10.3390/cells8111409

Simón Serrano, Sonia, Alvar Grönberg, Lisa Longato, Krista Rombouts, Joseph Kuo, Matthew Gregory, Steven Moss, Eskil Elmér, Giuseppe Mazza, Philippe Gallay, and et al. 2019. "Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis" Cells 8, no. 11: 1409. https://doi.org/10.3390/cells8111409

Simón Serrano, S., Grönberg, A., Longato, L., Rombouts, K., Kuo, J., Gregory, M., Moss, S., Elmér, E., Mazza, G., Gallay, P., Pinzani, M., Hansson, M. J., & Massoumi, R. (2019). Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis. Cells, 8(11), 1409. https://doi.org/10.3390/cells8111409